Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherWages, Salaries and Other
Ratios

Spero Therapeutics (SPRO) Preferred Shares Issued (2017 - 2020)

Spero Therapeutics' Preferred Shares Issued history spans 2 years, with the latest figure at -$9.6 million for Q4 2020.

  • For Q4 2020, Preferred Shares Issued changed N/A year-over-year to -$9.6 million; the TTM value through Dec 2020 reached $20.6 million, changed N/A, while the annual FY2020 figure was $20.6 million, N/A changed from the prior year.
  • Preferred Shares Issued reached -$9.6 million in Q4 2020 per SPRO's latest filing, down from $9.6 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $43.0 million in Q1 2017 to a low of -$9.6 million in Q4 2020.